Corrigendum to “Route of Administration for UGN-101 and Impact on Oncological and Safety Outcomes” [Eur. Urol. Focus (2023)] (European Urology Focus (2023) 9(6) (1052–1058), (S2405456923001232), (10.1016/j.euf.2023.05.012))

Jennifer Linehan, Josh Gottlieb, Solomon L. Woldu, Craig Labbate, Kyle Rose, Wade Sexton, Hristos Kaimakliotis, Joseph Jacob, Rian Dickstein, Alan Nieder, Marc Bjurlin, Mitchell Humphreys, Saum Ghodoussipour, Marcus Quek, Michael O'Donnell, Brian H. Eisner, Adam S. Feldman, Surena F. Matin, Yair Lotan, Katie S. Murray

Research output: Contribution to journalComment/debatepeer-review

Abstract

The authors regret, that there were 2 missed corrections on the final proof. The corresponding author, Josh Gottlieb, was incorrectly listed to have affiliation “b” for University of Texas Southwestern Medical Center. Josh Gottlieb's correct affiliation should be the same as the first author, Jennifer Linehan (Providence Specialty Medical Group). In addition, Dr. Saum Ghodoussipour (correct spelling) was spelled incorrectly as Ghodoussipor (incorrect spelling) on the final proof. The corrections are updated as above. The authors would like to apologise for any inconvenience caused.

Original languageEnglish (US)
Pages (from-to)211
Number of pages1
JournalEuropean Urology Focus
Volume10
Issue number1
DOIs
StatePublished - Jan 2024

ASJC Scopus subject areas

  • Urology

Fingerprint

Dive into the research topics of 'Corrigendum to “Route of Administration for UGN-101 and Impact on Oncological and Safety Outcomes” [Eur. Urol. Focus (2023)] (European Urology Focus (2023) 9(6) (1052–1058), (S2405456923001232), (10.1016/j.euf.2023.05.012))'. Together they form a unique fingerprint.

Cite this